Trial Profile
Clinical Trials Insight: 700031709
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 19 Mar 2008
Price :
$35
*
At a glance
- Drugs Lonidamine (Primary) ; Antineoplastics
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Threshold Pharmaceuticals
- 19 Mar 2008 New trial record.